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Abstract 
 The molecular mechanisms that govern intracellular transport of sterols in 
eukaryotic cells are only poorly understood. Saccharomyces cerevisiae is a facultative 
anaerobic organism that requires supplementation with unsaturated fatty acids and 
sterols to grow in the absence of oxygen, as the synthesis of these lipids requires 
molecular oxygen. The fact that yeast grows well under anaerobic conditions indicates 
that lipid uptake is rapid and efficient. To identify components in this lipid uptake and 
transport pathway, we screened the yeast mutant collection for genes that are essential 
under anaerobic conditions. Of the ~4800 nonessential genes represented in the 
mutant collection, 37 were required for growth under anaerobic conditions. Uptake 
assays using radiolabeled cholesterol revealed that 16 of these genes are required for 
cholesterol uptake/transport and esterification. Further characterization of the precise 
role of these genes is likely to advance our understanding of this elusive pathway in 
yeast and may prove to be relevant to understand sterol homeostasis in higher 
eukaryotic cells. 
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INTRODUCTION 
Sterols are important lipid components of eukaryotic membranes that 
determine many membrane characteristics and are required for polar sorting events 
during vesicle transport in animal, plant, and fungal cells [1-3]. 
Due to the importance of cholesterol in various cell functions, it is crucial that 
its levels and intracellular distribution are tightly controlled (for review see [4-6]). 
Cholesterol is synthesized in the endoplasmic reticulum and subsequently transported 
to the plasma membrane, which harbors ~90% of the free sterol pool of the cell [7]. 
The nature of this transport process is poorly understood but may involve both 
vesicular and non-vesicular components. Delivery of newly synthesized cholesterol to 
the plasma membrane is ATP-dependent, but only partially sensitive to brefeldin A 
[8-11]. 
Mammalian cells take up exogenous cholesterol by receptor-mediated 
endocytosis of low-density lipoproteins (LDL) [12]. Once delivered to late endosomes 
or lysosomes, LDL-derived cholesteryl esters are hydrolyzed, and free cholesterol is 
rapidly cycled back to the plasma membrane and/or the endoplasmic reticulum for 
esterification. Maintenance of the cycle between free and esterified sterols thus relies 
on a bidirectional transport of sterols between the endoplasmic reticulum and the 
plasma membrane and/or an endocytic compartment [13-18]. The molecular nature of 
this cycle is poorly understood. Movement of cholesterol from the plasma membrane 
to the endoplasmic reticulum of mammalian cells is inhibited by hydrophobic amines, 
progesterone, disruption of the cytoskeleton or that of the acidic compartments, but 
not by ATP depletion [19-22]. The cholesterol transport cycle is interrupted in certain 
lipid storage diseases. Most notably in Niemann-Pick type C1 disease, where 
cholesterol accumulates in an endosomal compartment, or in atherosclerotic 
- 4 - 
macrophages, where an excess of free sterol in the endoplasmic reticulum induces 
apoptosis [23-26]. 
 
Sterol uptake and transport in yeast 
Yeast is a valuable model organism to characterize basic cellular processes 
that are conserved in all eukaryotic cells. S. cerevisiae has been established as a model 
organism to study intracellular sterol transport and homeostasis by Sturley and 
coworkers [27, 28]. The basic steps of sterol synthesis in yeast are the same as in 
higher eukaryotic cells, even though this fungus synthesizes ergosterol instead of 
cholesterol [29]. As in mammalian cells, ergosterol is synthesized in the endoplasmic 
reticulum, transported by a poorly characterized mechanism to the plasma membrane, 
and excess of free sterol is esterified by two acyl CoA:cholesterol acyltransferases 
[30, 31]. The resulting steryl esters are then deposited into intracellular lipid particles 
from where they can be mobilized by three different steryl ester hydrolases: Yeh1, 
Yeh2 and Tgl1 [32]. 
Saccharomyces cerevisiae does not take up exogenous sterol under aerobic 
conditions, but cells are sterol auxotroph in the absence of oxygen or if they are not 
able to synthesize heme [33, 34]. The molecular basis for the exclusion of sterols 
under aerobic conditions is not well understood, but it can partially be overcome by 
expression of a hypermorphic allele of the transcription factor UPC2 or by 
overexpression of the transcriptional regulator SUT1 [35, 36]. Aerobic uptake of 
sterols in the UPC2-1 mutant appears to be mediated by upregulation of two ABC 
transporters, PDR11 and AUS1, and a putative cell wall protein, Dan1[37, 38]. 
Consistent with a role of the two ABC transporters in sterol uptake, a pdr11∆ aus1∆ 
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double mutant does not grow under anaerobic conditions and the double mutant has a 
greatly reduced rate of steryl ester formation [37, 39]. A defect in sterol uptake and 
impaired growth under anaerobic conditions was also observed in cells that lack 
ARV1, a gene that is required for viability of cells that lack steryl esters [40]. ARV1 
encodes a conserved protein with 6 putative transmembrane domains and localizes to 
the endoplasmic reticulum and Golgi membranes [41]. In addition to their defect in 
sterol uptake, arv1∆ mutants have pleiotropic defects in sphingolipids, phospholipids 
and sterol metabolism [41]. 
 
A screen for sterol uptake and transport mutants  
We became interested in sterol trafficking because we isolated mutants in the 
sterol biosynthetic pathway as being synthetic lethal with mutants in fatty acid 
elongation. Subsequent work then showed that the combination of defects in certain 
sterol modifications with defects in sphingolipid synthesis affects raft association and 
the stability of integral membrane proteins [42]. These and the observations made by 
others (see above) indicate that sterol trafficking is intimately related to sphingolipid 
metabolism in yeast and mammalian cells. 
In an ab initio approach to identify genes that are involved in sterol 
trafficking, we screened the yeast deletion mutant collection for genes that are 
required for growth under anaerobic conditions. Of approximately 37 mutants isolated 
in this screen, 16 affected sterol uptake and/or trafficking as assessed by genetic and 
biochemical analyses. When combined with mutations in hem1, these strains failed to 
grow on media containing sterols (ergosterol or cholesterol) and unsaturated fatty 
acids. The lack of HEM1 can either be overcome by supplementing cells with sterols 
and unsaturated fatty acids or can be bypassed by supplementing the cells with delta-
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aminolevulinic acid, the enzymatic product of the first step in hem biosynthesis 
catalyzed by Hem1 [43]. Importantly, all of these uptake mutants grew normally if the 
block imposed by hem1 is bypassed by the addition of delta-aminolevulinic acid to the 
media, which is consistent with a defect in lipid uptake/trafficking (Figure 1). When 
incubated with [14C]-cholesterol, the mutants failed to take up the label and they 
showed no or greatly reduced levels of radiolabeled free and esterified cholesterol 
(Figure 2). Incubations with [3H]-palmitate, however, indicate that these mutants have 
no defects in fatty acid uptake and incorporation of exogenous fatty acids into lipids 
(Reiner et al., manuscript submitted). Furthermore, the sterol transport defect in these 
mutants could be visualized using a fluorescent cholesterol derivative, NBD-
cholesterol [44, 45]. Heme-deficient wild-type cells incubated with NBD-cholesterol 
displayed intense staining of the plasma membrane and staining of intracellular lipid 
particles. The sterol uptake mutants, on the other hand, showed no or only little 
staining of the plasma membrane and the intracellular lipid particles (Figure 3). 
Taken together, the results of this screen for sterol uptake and transport 
mutants in yeast revealed 16 genes that are required for growth under anaerobic 
conditions and for the efficient uptake of cholesterol. Aim of future studies now is to 
characterize the sterol trafficking defect of these mutants in more detail and to 
understand the role of the respective genes in the putative sterol transport pathway. 
Results of such studies are likely to be relevant for the pathology of certain human 
lipid storage diseases and to understand sterol homeostasis at a cellular level. 
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Figure legends 
Figure 1. Growth of anaerobic non-viable mutants in a heme-deficient background.  
Heme-deficient wild-type and uptake mutant cells were 10-fold serially diluted and 
spotted on YPD media containing cholesterol (Chol/Tw) or ergosterol (Erg/Tw) and 
Tween 80 as a source for unsaturated fatty acids, YPD media containing delta-
aminolevulinic acid (ALA), and on non-supplemented YPD media (Non-suppl.). 
Plates were incubated under aerobic conditions for 4 days at 30°C.  
 
Figure 2. Uptake and esterification of [14C]-cholesterol. 
Heme-deficient wild-type and uptake mutant cells were grown in the presence of 
[14C]-cholesterol and Tween 80 for 48 h at 24°C. Equal OD units of cells were 
harvested, lipids were extracted, separated by TLC, and [14C]cholesterol in the free 
and esterified sterol fraction was quantified by radio scanning. 
 
Figure 3. Subcellular localization of NBD-cholesterol. 
Heme-deficient wild-type and uptake mutant cells were grown in the presence of 
NBD-cholesterol for 24 h at 24°C and NBD-cholesterol localization was examined by 
fluorescent microscopy using identical exposure settings. Plasma membrane and lipid 
particle staining is indicated by arrows and arrowheads, respectively. Nomarski view 
of the same visual field is shown below. Bar, 5 µm. 
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